Obsessive Compulsive Foundation   Report issue

Foundation Phase 2
Founded: Boston MA United States (1986)

Organization Overview

First Clinical Trial
2004
NCT00405535
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Obsessive Compulsive Foundation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Compulsive Personality Disorder (Phase 2)

Disease (Phase 2)

Mental Disorders (Phase 2)

Obsessive-Compulsive Disorder (Phase 2)

Problem Behavior (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 7